MedPath
TGA Approval

BEVACIP bevacizumab 100 mg/4 mL concentrated solution for infusion vial (347290)

347290

BEVACIP bevacizumab 100 mg/4 mL concentrated solution for infusion vial

Cipla Australia Pty Ltd

November 2, 2021

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/752239e879f9d14f7027b1f364fdb149.pdf

Active Ingredients

Bevacizumab

© Copyright 2025. All Rights Reserved by MedPath
BEVACIP bevacizumab 100 mg/4 mL concentrated solution for infusion vial (347290) - TGA 批准文号 | MedPath